Package 72603-270-01

Brand: bortezomib

Generic: bortezomib
NDC Package

Package Facts

Identity

Package NDC 72603-270-01
Digits Only 7260327001
Product NDC 72603-270
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (72603-270-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2024-11-01
Brand bortezomib
Generic bortezomib
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "27ad9395-c6d2-f500-ab18-07278b7c7b0e", "openfda": {"nui": ["N0000175604", "N0000175075"], "upc": ["0372603270013"], "unii": ["69G8BD63PP"], "rxcui": ["402243"], "spl_set_id": ["3f02670b-5683-780c-9d38-5d8f0ef43a14"], "pharm_class_epc": ["Proteasome Inhibitor [EPC]"], "pharm_class_moa": ["Proteasome Inhibitors [MoA]"], "manufacturer_name": ["NorthStar RxLLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (72603-270-01)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE", "package_ndc": "72603-270-01", "marketing_start_date": "20241101"}], "brand_name": "Bortezomib", "product_id": "72603-270_27ad9395-c6d2-f500-ab18-07278b7c7b0e", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Proteasome Inhibitor [EPC]", "Proteasome Inhibitors [MoA]"], "product_ndc": "72603-270", "generic_name": "Bortezomib", "labeler_name": "NorthStar RxLLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bortezomib", "active_ingredients": [{"name": "BORTEZOMIB", "strength": "3.5 mg/1"}], "application_number": "ANDA202963", "marketing_category": "ANDA", "marketing_start_date": "20241101", "listing_expiration_date": "20261231"}